V2 sact_regimen
781,388 rows · 12 columns
| ENCORE_PATIENT_ID | MERGED_REGIMEN_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | BENCHMARK_GROUP | LINK_NUMBER |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 10143751 | 10072105 | 1.66 | 77.4 | null | 2022-05-02 | 2022-05-02 | NIVOLUMAB | 02 | null | NIVOLUMAB | 100323751 |
| 10146407 | 10072106 | 1.79 | 75.6 | Palliative (P) | 2019-09-28 | 2020-11-28 | Avelumab | 02 | N | AVELUMAB | 100737526 |
| 10161709 | 10072108 | 1.73 | 56.4 | Palliative (P) | 2020-12-08 | 2021-01-10 | DARATUMUMAB | 02 | null | BENDAMUSTINE + RITUXIMAB | 100645879 |
| 10168334 | 10072109 | null | 67.8 | Adjuvant (A) | 2022-04-19 | 2022-04-19 | Irinotecan + Modified De Gramont | 02 | N | FLUOROURACIL + IRINOTECAN | 101071948 |
| 10170001 | 10072110 | 1.88 | 0 | null | 2021-03-10 | 2021-03-11 | NIVOLUMAB | 02 | null | NIVOLUMAB | 101077469 |
| 10186199 | 10072112 | 1.69 | 151.2 | null | 2020-05-26 | 2020-05-27 | DARATUMUMAB | 2 | null | DARATUMUMAB | 101743237 |
| 10191357 | 10072113 | 1.52 | 69.8 | null | 2021-10-30 | 2022-01-01 | Avelumab | N | null | FLUOROURACIL + IRINOTECAN | 100572795 |
| 10203444 | 10072114 | 1.49 | 71.4 | Palliative (P) | 2021-03-12 | 2022-02-11 | Avelumab | 02 | N | AVELUMAB | 101769905 |
| 10206060 | 10072116 | 1.55 | 103 | null | 2020-05-06 | 2020-05-07 | Avelumab | 02 | null | CAPECITABINE + OXALIPLATIN | 100933397 |
| 10209468 | 10072117 | 1.64 | 71.8 | null | 2020-06-22 | 2020-08-11 | DARATUMUMAB | 02 | null | DARATUMUMAB | 100484995 |
| 10209795 | 10072118 | 1.75 | 79.6 | null | 2022-02-03 | 2022-02-10 | FLUOROURACIL + OXALIPLATIN | 02 | null | FLUOROURACIL + OXALIPLATIN | 100460136 |
| 10209860 | 10072119 | 1.73 | 81.75 | null | 2020-02-10 | 2020-02-14 | DARATUMUMAB | 02 | null | DARATUMUMAB | 101658124 |
| 10210868 | 10072121 | 1.66 | 92.7 | Palliative (P) | 2021-10-16 | 2022-02-07 | CAPECITABINE + OXALIPLATIN | 02 | N | CAPECITABINE + OXALIPLATIN | 100490163 |
| 10214003 | 10072123 | 1.67 | 69.8 | Palliative (P) | 2021-06-24 | 2021-07-15 | Avelumab | 02 | N | FLUOROURACIL + OXALIPLATIN | 101153356 |
| 10226863 | 10072125 | 1.53 | 75.2 | null | 2021-10-11 | 2022-03-23 | NIVOLUMAB | 02 | null | NIVOLUMAB | 101573223 |
| 10230784 | 10072126 | 1.7 | 67.4 | null | 2021-10-17 | 2021-10-21 | Avelumab | 02 | null | NIVOLUMAB | 101146406 |
| 10232178 | 10072127 | 1.7 | 70.9 | Palliative (P) | 2017-08-22 | 2019-04-03 | Trastuzumab Subcutaneous | 02 | N | TRASTUZUMAB | 101522131 |
| 10236447 | 10072130 | 1.76 | 68.3 | null | 2022-01-12 | 2022-01-27 | Avelumab | 02 | null | AVELUMAB | 100303527 |
| 10240641 | 10072132 | 0 | 77 | null | 2021-09-29 | 2021-11-24 | Avelumab | 02 | null | BENDAMUSTINE + RITUXIMAB | 101087869 |
| 10241543 | 10072134 | null | 59.7 | Curative (C) | 2020-12-27 | 2021-01-29 | Avelumab | 02 | N | CAPECITABINE + OXALIPLATIN | 100279137 |
| 10244691 | 10072137 | null | 66 | Adjuvant (A) | 2020-09-14 | 2020-10-11 | Bendamustine+Rituximab(Sub Courses) | 02 | N | BENDAMUSTINE + RITUXIMAB | 101703537 |
| 10245192 | 10072139 | 1.68 | 73.5 | null | 2016-09-08 | 2016-10-23 | Avelumab | 02 | null | CAPECITABINE + OXALIPLATIN | 101154702 |
| 10246813 | 10072141 | 1.86 | null | Palliative (P) | 2018-04-09 | 2018-05-07 | NIVOLUMAB | 02 | Y | CAPECITABINE + OXALIPLATIN | 101236487 |
| 10246828 | 10072142 | 1.72 | null | null | 2018-04-30 | 2018-08-06 | Irinotecan + Modified De Gramont | 02 | N | FLUOROURACIL + IRINOTECAN | 100591051 |
| 10247087 | 10072143 | 1.7 | 47.6 | Palliative (P) | 2018-11-06 | 2018-11-12 | Capecitabine + Oxaliplatin 21day | 02 | null | CAPECITABINE + OXALIPLATIN | 101009672 |
| 10247273 | 10072144 | 1.51 | 82 | null | 2022-04-22 | 2022-04-29 | Avelumab | 02 | null | AVELUMAB | 100081496 |
| 10248241 | 10072145 | 1.55 | 58 | Palliative (P) | 2019-08-24 | 2019-08-24 | Avelumab | 02 | null | NIVOLUMAB | 101217659 |
| 10248541 | 10072146 | 1.74 | 72 | 03 | 2019-11-17 | 2019-11-18 | Avelumab | 02 | N | FLUOROURACIL + OXALIPLATIN | 101650635 |
| 10248640 | 10072147 | 1.68 | 45.8 | null | 2020-01-16 | 2020-01-22 | Trastuzumab Subcutaneous | 02 | null | VENETOCLAX | 100619761 |
| 10249969 | 10072148 | 1.79 | 45.8 | null | 2019-11-18 | 2019-11-26 | Avelumab | 02 | null | CAPECITABINE + OXALIPLATIN | 101310758 |
| 10250430 | 10072150 | 1.67 | 87.2 | Palliative (P) | 2017-10-09 | 2017-10-23 | CEMIPLIMAB | null | N | CEMIPLIMAB | 100992262 |
| 10254140 | 10072153 | 1.69 | 73.5 | Neo-adjuvant (N) | 2016-06-21 | 2016-07-26 | GEMCARBO | 02 | N | CARBOPLATIN + GEMCITABINE | 100222606 |
| 10255434 | 10072154 | 1.84 | 56 | Adjuvant (A) | 2019-01-01 | 2019-01-16 | Avelumab | 02 | N | AVELUMAB | 100560679 |
| 10255810 | 10072156 | 1.67 | 64 | 03 | 2017-11-07 | 2017-11-12 | Avelumab | 02 | N | AVELUMAB | 101728894 |
| 10256135 | 10072157 | 1.58 | 76.9 | null | 2016-10-03 | 2018-06-24 | Venetoclax | 02 | null | VENETOCLAX | 100184230 |
| 10256803 | 10072158 | 1.7 | 72 | null | 2020-06-20 | 2020-06-23 | BENDAMUSTINE + RITUXIMAB | 02 | null | BENDAMUSTINE + RITUXIMAB | 100641700 |
| 10256853 | 10072159 | null | 77.4 | 03 | 2021-09-10 | 2021-10-10 | RUXOLITINIB | 02 | N | RUXOLITINIB | 101637772 |
| 10257928 | 10072160 | 1.75 | 58.7 | 03 | 2020-06-08 | 2020-06-26 | Avelumab | 02 | N | VENETOCLAX | 101705529 |
| 10258965 | 10072161 | 1.8 | 73.9 | Palliative (P) | 2019-03-11 | 2019-03-19 | NIVOLUMAB | 02 | N | NIVOLUMAB | 100800145 |
| 10260903 | 10072165 | 1.77 | 78.5 | Palliative (P) | 2018-06-07 | 2018-08-08 | Avelumab | 02 | N | BENDAMUSTINE + RITUXIMAB | 101188771 |
| 10261350 | 10072166 | 1.81 | 98 | null | 2017-04-18 | 2017-04-18 | Avelumab | 02 | null | CARBOPLATIN + GEMCITABINE | 101300976 |
| 10261611 | 10072167 | 1.68 | 0 | Palliative (P) | 2018-06-24 | 2018-06-25 | Trastuzumab Subcutaneous | 02 | N | TRASTUZUMAB | 101239525 |
| 10261830 | 10072168 | 1.75 | 79.6 | Disease modification (D) | 2018-02-19 | 2018-02-19 | NIVOLUMAB | 02 | null | NIVOLUMAB | 101479438 |
| 10262517 | 10072169 | 1.78 | 99.3 | Palliative (P) | 2017-04-06 | 2017-05-07 | Bendamustine+Rituximab(Sub Courses) | 02 | N | BENDAMUSTINE + RITUXIMAB | 101346884 |
| 10263126 | 10072170 | 1.53 | 62.2 | 03 | 2015-04-23 | 2016-07-21 | CEMIPLIMAB | 02 | N | CEMIPLIMAB | 100320337 |
| 10263882 | 10072171 | 1.62 | 73.5 | Palliative (P) | 2018-10-23 | 2019-08-19 | NIVOLUMAB | 02 | N | AVELUMAB | 100139498 |
| 10264301 | 10072172 | 1.65 | 84.5 | Adjuvant (A) | 2019-11-18 | 2019-11-23 | Avelumab | 02 | N | AVELUMAB | 100908814 |
| 10264477 | 10072173 | 1.63 | 81 | Palliative (P) | 2017-08-31 | 2017-12-08 | Avelumab | 02 | N | AVELUMAB | 100645930 |
| 10264975 | 10072174 | 1.75 | 67.9 | Neo-adjuvant (N) | 2016-12-30 | 2019-08-04 | CAPECITABINE + OXALIPLATIN | 02 | N | CAPECITABINE + OXALIPLATIN | 101673457 |
| 10265879 | 10072175 | 1.62 | 86 | Adjuvant (A) | 2019-09-27 | 2019-11-04 | DARATUMUMAB | 02 | N | DARATUMUMAB | 100648458 |